CD19 function in central and peripheral B-cell development

Immunologic Research

Volumn 31, Issue 2, 2005, Pages 119-131

  Del Nagro, Christopher J ^a   Otero, Dennis C ^a   Anzelon, Amy N ^a   Anzelon, Sidne N ^a   Kolla, Ravi V ^a   Rickert, Robert C ^a,b  

^a BURNHAM INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

B cell; B 1 cell; CD19; CD21; Co receptor; Germinal center; Marginal zone; PI3 kinase

Indexed keywords

B LYMPHOCYTE ANTIGEN; B LYMPHOCYTE RECEPTOR; BCR ABL PROTEIN; CD19 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CONTROLLED STUDY; GERMINAL CENTER; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 18244392670     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:31:2:119     Document Type: Review

References (93)

1. Tedder TF, Isaacs CM: Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes. A new member of the immunoglobulin superfamily. J Immunol 1989;143:712.
2. Bradbury LE, Goldmacher VS, Tedder TF: The CD19 signal transduction complex of B lymphocytes. Deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu 13. J Immunol 1993;151:2915.
3. Matsumoto AK, Martin DR, Carter RH, et al.: Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes. J Exp Med 1993;178:1407.
4. Fearon DT, Carroll MC: Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu Rev Immunol 2000;18:393.
5. Carter RH, Fearon DT: CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 1992;256:105.
6. Dempsey PW, Allison ME, Akkaraju S, et al.: C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 1996;271:348.
7. Krop I, de Fougerolles AR, Hardy RR, et al.: Self-renewal of B-1 lymphocytes is dependent on CD19. Eur J Immunol 1996;26:238.
8. Wolf ML, Weng WK, Stieglbauer KT, et al.: Functional effect of IL-7-enhanced CD19 expression on human B cell precursors. J Immunol 1993;151:138.
9. Krop I, Shaffer AL, Fearon DT, Schlissel MS: The signaling activity of murine CD19 is regulated during cell development. J Immunol 1996;157:48.
10. Otero DC, Rickert RC: CD19 function in early and late B cell development. II. CD19 facilitates the Pro-B/Pre-B transition. J Immunol 2003;171:5921.
11. Billips LG, Nunez CA, Bertrand FER, et al.: Immunoglobulin recombinase gene activity is modulated reciprocally by interleukin 7 and CD19 in B cell progenitors. J Exp Med 1995;182:973.
12. Buhl AM, Nemazee D, Cambier JC, et al.: B-cell antigen receptor competence regulates B-lymphocyte selection and survival. Immunol Rev 2000;176:141.
13. Shivtiel S, Leider N, Sadeh O, et al.: Impaired light chain allelic exclusion and lack of positive selection in immature B cells expressing incompetent receptor deficient of CD19. J Immunol 2002;168:5596.
14. !4. Engel P, Zhou LJ, Ord DC, et al.: Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 1995;3:39.
15. Benschop RJ, Cambier JC: B cell development: signal transduction by antigen receptors and their surrogates. Curr Opin Immunol 1999;11:143.
16. Sato S, Steeber DA, Jansen PJ, Tedder TF: CD19 expression levels regulate B lymphocyte development: human CD19 restores normal function in mice lacking endogenous CD19. J Immunol 1997;158:4662.
17. Nemazee DA, Bürki K: Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 1989;337:562.
18. Goodnow CC, Crosbie J, Adelstein S, et al.: Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988;334:676.
19. Lavoie TB, Drohan WN, Smith-Gill SJ: Experimental analysis by site-directed mutagenesis of somatic mutation effects on affinity and fine specificity in antibodies specific for lysozyme. J Immunol 1992;148:503.
20. Prodeus AP, Goerg S, Shen LM, et al.: A critical role for complement in maintenance of self-tolerance. Immunity 1998;9:721.
21. Inaoki M, Sato S, Weintraub BC, Goodnow CC, Tedder TF: CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J Exp Med 1997;186:1923.
22. Hasegawa M, Fujimoto M, Poe JC, et al.: CD19 can regulate B lymphocyte signal transduction independent of complement activation. J Immunol 2001;167:3190.
23. Otero DC, Anzelon AN, Rickert RC: CD19 function in early and late B cell development: I. Maintenance of follicular and marginal zone B cells requires CD19-dependent survival signals. J Immunol 2003;170:73.
24. Lam KP, Kuhn R, Rajewsky K: In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death [see comments]. Cell 1997;90:1073.
25. Roberts T, Snow EC: Cutting edge: recruitment of the CD19/CD21 coreceptor to B cell antigen receptor is required for antigen-mediated expression of Bcl-2 by resting and cycling hen egg lysozyme transgenic B cells. J Immunol 1999;162:4377.
26. Carter RH, Fearon DT: Polymeric C3dg primes human B lymphocytes for proliferation induced by anti-IgM. J Immunol 1989;143:1755.
27. Rickert RC, Rajewsky K, Roes J: Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficientmice. Nature 1995;376:352.
28. Martin F, Kearney JF: Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity 2000; 12:39.
29. Wortis HH, Berland R: Cutting edge commentary: origins of B-1 cells. J Immunol 2001;166:2163.
30. Martin F, Oliver AM, Kearney JF: Marginal zone and B1 B cells unite in the early response against T-independent blood-borne paniculate antigens. Immunity 2001; 14:617.
31. Cariappa A, Tang M, Parng C, et al.: The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity 2001;14:603.
32. Guinamard R, Okigaki M, Schlessinger J, Ravetch JV: Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat Immunol 2000;1:31.
33. Fukui Y, Hashimoto O, Sanui T, et al.: Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration. Nature 2001;412:826.
34. Girkontaite I, Missy K, Sakk V, et al.: Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses. Nat Immunol 2001;2:855.
35. Lu TT, Cyster JG: Integrin-mediated long-term B cell retention in the splenic marginal zone. Science 2002; 297:409.
36. Chalupny NJ, Aruffo A, Esselstyn JM, et al.: Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains. Eur J Immunol 1995;25:2978.
37. Fehr T, Rickert RC, Odermatt B, et al.: Antiviral protection and germinal center formation, but impaired B cell memory in the absence of CD19. J Exp Med 1998;188:145.
38. Liu YJ, Oldfield S, MacLennan IC: Memory B cells in T cell-dependent antibody responses colonize the splenic marginal zones. Eur J Immunol 1988;18:355.
39. Song H, Cerny J: Functional heterogeneity of marginal zone B cells revealed by their ability to generate both early antibody-forming cells and germinal centers with hypermutation and memory in response to a T-dependent antigen. J Exp Med 2003;198:1923.
40. Attanavanich K, Kearney JF: Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J Immunol 2004;172:803.
41. Barrington R, Zhang M, Fischer M, Carroll MC: The role of complement in inflammation and adaptive immunity. Immunol Rev 2001;180:5.
42. Cherukuri A, Cheng PC, Pierce SK: The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigens. J Immunol 2001;167:163.
43. Gardby E, Chen XJ, Lycke NY: Impaired CD40-signalling in CD19-deficient mice selectively affects Th2-dependent isotype switching. Scand J Immunol 2001;53:13.
44. Kawabe T, Naka T, Yoshida K, et al.: The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1994;1:167.
45. Randall TD, Heath AW, Santos-Argumedo L, et al.: Arrest of B lymphocyte terminal differentiation by CD40 signaling: mechanism for lack of antibody-secreting cells in germinal centers. Immunity 1998;8:733.
46. Han S, Hathcock K, Zheng B, et al.: Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers. J Immunol 1995;155:556.
47. Wang Y, Brooks SR, Li X, et al.: The physiologic role of CD19 cytoplasmic tyrosines. Immunity 2002;17:501.
48. Chalupny NJ, Kanner SB, Schieven GL, et al.: Tyrosine phosphorylation of CD19 in pre-B and mature B cells. Embo J 1993;12:2691.
49. Fujimoto M, Fujimoto Y, Poe JC, et al.: CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification. Immunity 2000;13:47.
50. Buhl AM, Cambier JC: Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase. J Immunol 1999;162:4438.
51. Brooks SR, Li X, Volanakis EJ, Carter RH: Systematic analysis of the role of CD19 cytoplasmic tyrosines in enhancement of activation in Daudi human B cells: clustering of phospholipase C and Vav and of Grb2 and Sos with different CD19 tyrosines. J Immunol 2000; 164:3123.
52. Tuveson DA, Carter RH, Soltoff SP, Fearon DT: CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science 1993;260:986.
53. van Noesel CJ, Lankester AC, van Schijndel GM, van Lier RA: The CR2/CD19 complex on human B cells contains the src-family kinase Lyn. Int Immunol 1993;5:699.
54. Xu Y, Beavitt S-JE, Harder KW, et al.: The activation and subsequent regulatory roles of Lyn and CD19 after B cell receptor ligation are independent. J Immunol 2002; 169:6910.
55. Beitz LO, Fruman DA, Kurosaki T, et al.: SYK is upstream of phosphoinositide 3-kinase in B cell receptor signaling. J Biol Chem 1999;274:32662.
56. Yokozeki T, Adler K, Lankar D, Bonnerot C: B cell receptor-mediated Syk-independent activation of phosphatidylinositol 3-kinase, Ras, and mitogen-activated protein kinase pathways. J Immunol 2003;171:1328.
57. Buhl AM, Pleiman CM, Rickert RC, Cambier JC: Qualitative regulation of B cell antigen receptor signaling by CD19: selective requirement for PI3-kinase activation, inositol-1,4,5-trisphosphate production and Ca2+ mobilization. J Exp Med 1997;186:1897.
58. Fujimoto M, Poe JC, Satterthwaite AB, et al.: Complementary roles for CD19 and Bruton's tyrosine kinase in B lymphocyte signal transduction. J Immunol 2002; 168:5465.
59. Otero DC, Omori SA, Rickert RC: Cd19-dependent activation of Akt kinase in B-lymphocytes. J Biol Chem 2001;276:1474.
60. Kurosaki T: Regulation of B-cell signal transduction by adaptor proteins. Nature Rev Immunol 2002;2:354.
61. Yamazaki T, Takeda K, Gotoh K, et al.: Essential immunoregulatory role for BCAP in B cell development and function. J Exp Med 2002;195:535.
62. Itoh S, Itoh M, Nishida K, et al.: Adapter molecule Grb2-associated binder 1 is specifically expressed in marginal zone B cells and negatively regulates thymus-independent antigen-2 responses. J Immunol 2002;168:5110.
63. Clark MR, Campbell KS, Kazlauskas A, et al: The B cell antigen receptor complex: association of Ig-alpha and Ig-beta with distinct cytoplasmic effectors. Science 1992;258:123.
64. Jou ST, Carpino N, Takahashi Y, et al.: Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex. Mol Cell Biol 2002;22:8580.
65. Clayton E, Bardi G, Bell SE, et al.: A crucial role for the p110{delta} subunit of phosphatidylinositol 3-kinase in B cell development and activation. J Exp Med 2002; 196:753.
66. Okkenhaug K, Bilancio A, Farjot G, et al.: Impaired B and T cell antigen receptor signaling in p110delta PI3-kinase mutant mice. Science 2002;297:1031.
67. Fruman DA, Snapper SB, Yballe CM, et al.: Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. Science 1999;283:393.
68. Fruman DA, Satterthwaite AB, Witte ON: Xid-like phenotypes: a B cell signalosome takes shape. Immunity 2000;13:1.
69. Suzuki H, Terauchi Y, Fujiwara M, et al.: 1999 Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. Science 1999;283:390.
70. Anzelon AN, Wu H, Rickert RC: Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function. Nat Immunol 2003;4:287.
71. Suzuki A, Kaisho T, Ohishi M, et al.: Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination. J Exp Med 2003;197:657.
72. Katan M, Allen VL: Modular PH and C2 domains in membrane attachment and other functions. FEBS Lett 1999;452:36.
73. Lawlor MA, Mora A, Ashby PR, et al.: Essential role of PDK1 in regulating cell size and development in mice. EMBO J 2002;21:3728.
74. Vanhaesebroeck B, Alessi DR: The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 346 Pt 2000;3:561.
75. O'Rourke LM, Tooze R, Turner M, et al.: CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav. Immunity 1998;8:635.
76. Rickert RC, Wloch MK, Hahn RL, Clarke SH: Binding analysis of antibodies produced by precursor and branchpoint intermediates of an anti-influenza hemagglutinin B cell clone. Parallel replacement mutations do not confer increased avidity for hemagglutinin. J Immunol 1995;154:2209.
77. Mills DM, Stolpa JC, Cambier JC: Cognate B cell signaling via MHC class II: Differential regulation of B cell antigen receptor and MHC class II/Ig-alphabeta signaling by CD22. J Immunol 2004;172:195.
78. Yazawa N, Fujimoto M, Sato S, et al.: CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes. Blood 2003.
79. Hippen KL, Buhl AM, D'Ambrosio D, et al.: Fc gammaRIIB1 inhibition of BCR-mediated phosphoinositide hydrolysis and Ca2+ mobilization is integrated by CD19 dephosphorylation. Immunity 1997;7:49.
80. Kitanaka A, Ito C, Coustan-Smith E, Campana D: CD38 ligation in human B cell progenitors triggers tyrosine phosphorylation of CD19 and association of CD19 with lyn and phosphatidylinositol 3-kinase. J Immunol 1997; 159:184.
81. Koncz G, Gergely J, Sarmay G: Fc gammaRIIb inhibits both B cell receptor- and CD19-induced Ca2+ mobilization in Fc gammaR-transfected human B cells. Int Immunol 1998;10:141.
82. Venkataraman C, Lu PJ, Buhl AM, et al.: CD72-mediated B cell activation involves recruitment of CD19 and activation of phosphatidylinositol 3-kinase. Eur J Immunol 1998;28:3003.
83. Bradbury LE, Kansas GS, Levy S, et al.: The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J Immunol 1992;149:2841.
84. Kiener PA, Lioubin MN, Rohrschneider LR, et al.: Coligation of the antigen and Fc receptors gives rise to the selective modulation of intracellular signaling in B cells. Regulation of the association of phosphatidylinositol 3-kinase and inositol 5-+-phosphatase with the antigen receptor complex. J Biol Chem 1997;272:3838.
85. Carter RH, Doody GM, Bolen JB, Fearon DT: Membrane IgM-induced tyrosine phosphorylation of CD19 requires a CD19 domain that mediates association with components of the B cell antigen receptor complex. J Immunol 1997;158:3062.
86. Hayashi K, Yamamoto M, Nojima T, et al.: Distinct signaling requirements for Dmu selection, IgH allelic exclusion, pre-B cell transition, and tumor suppression in B cell progenitors. Immunity 2003;18:825.
87. Conley ME, Rohrer J, Rapalus L, et al.: Defects in early B-cell development: comparing the consequences of abnormalities in pre-BCR signaling in the human and the mouse. Immunol Rev 2000;178:75.
88. Toothaker LE, Henjes AJ, Weis JJ: Variability of CR2 gene products is due to alternative exon usage and different CR2 alleles. J Immunol 1989;142:3668.
89. Molina H, Kinoshita T, Inoue K, et al.: A molecular and immunochemical characterization of mouse CR2. Evidence for a single gene model of mouse complement receptors 1 and 2. J Immunol 1990;145:2974.
90. Barel M, Le Romancer M, Frade R: Activation of the EBV/C3d receptor (CR2, CD21) on human B lymphocyte surface triggers tyrosine phosphorylation of the 95-kDa nucleolin and its interaction with phosphatidylinositol 3 kinase. J Immunol 2001;166:3167.
91. Cherukuri A, Cheng PC, Sohn HW, Pierce SK: The CD19/CD21 complex functions to prolong B cell antigen receptor signaling from lipid rafts. Immunity 2001;14:169.
92. Weng WK, Jarvis L, LeBien TW: Signaling through CD19 activates Vav/mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/phosphatidylinositol 3-kinase complex in human B cell precursors. J Biol Chem 1994;269:32514.
93. Zipfel PA, Grove M, Blackburn K, et al.: The c-Abl tyrosine kinase is regulated downstream of the B cell antigen receptor and interacts with CD19. J Immunol 2000;165:6872.